This study is in progress, not accepting new patients
A Study of JR-171 in Patients With Mucopolysaccharidosis I
Summary
- Location
- at Oakland, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Paul Harmatz
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Paul Harmatz
Professor, Pediatrics, School of Medicine. Authored (or co-authored) 202 research publications
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- JCR Pharmaceuticals Co., Ltd.
- ID
- NCT04227600
- Phase
- Phase 1/2 research study
- Study Type
- Interventional
- Participants
- Expecting 19 study participants
- Last Updated